BSE:GODAVARI   GODAVARI DRUGS LTD.
Inverse H&S / C&H Formation: Yearly Basis
C&H Price Trendline BreakOut
Vol. Consolidation/BreakOut

*With Upside, Trail SL*
*Book Profit as per Risk Appetite*

*Snapshot*
Estab. in 1987, engaged in manufacturing of APIs

Revenue /Profit Stable on Qtrly/Yrly Basis. Gaining Traction.
Moderate Leverage Growing TNW. Profits Retained
CF for Ops. Increasingly +ve
Improved RoA/RoE/RoCE for FY22.
Promoters Stake Up Since Mar’22 / DII Stake Stable

*Concern:*
High Revenue Dependence on Ciprofloxacin API
High Public Stake at 42.58%

*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.